Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Pharmacology Research & Perspectives|March 21, 2020
In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of atalurenRonald Kong, Jiyuan Ma, Seongwoo Hwang, et al.
European Journal of Clinical Pharmacology|June 6, 2023
A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitorTerri L Morton, Oscar L Laskin, Diksha Kaushik, et al.
Theranostics|August 27, 2025
Targeting the self-amplifying loop between ATF6 and SNAI1 to inhibit epithelial‒mesenchymal transition in fibrotic lesionsTong Wu, Yan Liu, Jiyuan Ma, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 30, 2021
In vitro metabolism, pharmacokinetics and drug interaction potentials of emvododstat, a DHODH inhibitorJiyuan Ma, Diksha Kaushik, Shirley Yeh, et al.
Clinical Pharmacology in Drug Development|December 14, 2022
First-in-Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15-Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral SclerosisLan Gao, Peter Giannousis, Martin Thoolen, et al.
Clinical and Translational Science|December 22, 2023
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With LeiomyosarcomaLan Gao, Diksha Kaushik, Brian A Van Tine, et al.
Molecular Cancer Therapeutics|October 25, 2018
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical PropertiesLiangxian Cao, Marla Weetall, Christopher Trotta, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 4